Related references
Note: Only part of the references are listed.Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
Robert J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer
S Faivre et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Novel approaches in the therapy of metastatic renal cell carcinoma
JS Lam et al.
WORLD JOURNAL OF UROLOGY (2005)
Renal cell carcinoma co-existent with other renal disease:: clinico-pathological features in pre-dialysis patients and those receiving dialysis or renal transplantation
R Peces et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Present status of renal cell carcinoma in dialysis patients in Japan: Questionnaire study in 2002
I Ishikawa
NEPHRON CLINICAL PRACTICE (2004)
Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease
NK Janzen et al.
UROLOGIC CLINICS OF NORTH AMERICA (2003)
Share Paper
